Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Michael Horton

2106 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Legal
  • News

Bausch Health to Appeal XIFAXAN Patent Decision to U.S. Court of Appeals for the Federal Circuit, Says Expects Decision To Issue Within 12-18 Months

By Michael Horton
August 10, 6:01 PM
Bausch Health Companies Inc. (TSX:BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, consistent with the company's July 28, 2022, press release, the U.S. District Court

BHC

Read More
1 minute read
  • Earnings
  • News

Excelerate Energy Q2 EPS $(0.08) May Not Compare To $0.11 Estimate, Sales $622.90M Beat $591.67M Estimate

By Michael Horton
August 10, 5:49 PM
Excelerate Energy (NYSE:EE) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $0.11 by 172.73 percent. The company reported quarterly sales of $622.90 million which beat the

EE

Read More
1 minute read
  • Earnings
  • News

DiaMedica Therapeutics Q2 EPS $(0.13) Beats $(0.18) Estimate

By Michael Horton
August 10, 5:21 PM
DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 23.53 percent increase over losses of $(0.17) per share

DMAC

Read More
1 minute read
  • News
  • Offerings

Inspira Technologies Files For Mixed-Securities Shelf Offering Of Up To $50M

By Michael Horton
August 10, 5:16 PM
-Reuters

IINN

Read More
1 minute read
  • News
  • Offerings

Bit Digital Files Prospectus Relates To Sale By Selling Shareholder Of Up To 20M Ordinary Shares Consisting Of Shares Issuable To Ionic Ventures

By Michael Horton
August 10, 5:13 PM
-Reuters

BTBT

Read More
1 minute read
  • News

‘Microsoft is cutting hundreds of contractors amid layoffs and a hiring freeze’ -Business Insider

By Michael Horton
August 10, 4:53 PM
https://www.businessinsider.com/microsoft-is-ending-contracts-early-for-hundreds-of-workers-2022-8?IR=T

MSFT

Read More
2 minute read
  • News

IGT and Nisqually Red Wind Casino Team Up in Multi-Year Sports Betting Agreement, No Terms Disclosed

By Michael Horton
August 10, 4:41 PM
International Game Technology PLC ("IGT") (NYSE:IGT) announced today that it is expanding its sports betting leadership in Washington State via a multi-year contract with Nisqually Red Wind Casino.

IGT

Read More
1 minute read
  • Earnings
  • News

Forward Industries Q3 EPS $(0.04) Down From $0.02 YoY, Sales $10.59M Up From $9.96M YoY

By Michael Horton
August 10, 4:39 PM
Forward Industries (NASDAQ:FORD) reported quarterly losses of $(0.04) per share. This is a 300 percent decrease over earnings of $0.02 per share from the same period last year. The company reported $10.59 million in

FORD

Read More
4 minute read
  • Biotech
  • General
  • News

Rani Therapeutics Announces Topline Results from Phase 1 Study of RT-102 in Osteoporosis

By Michael Horton
August 10, 4:35 PM
Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (NASDAQ:RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced positive

RANI

Read More
1 minute read
  • Earnings
  • News

Fuel Tech Q2 EPS $0.01 Beats $(0.03) Estimate, Sales $6.37M Beat $6.13M Estimate

By Michael Horton
August 10, 4:33 PM
Fuel Tech (NASDAQ:FTEK) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.03) by 133.33 percent. This is a 133.33 percent increase over losses of $(0.03) per share from the

FTEK

Posts pagination

Previous 1 … 183 184 185 … 211 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service